Mentor, OH, United States of America

Alex Hlynsky

This inventor holds 3 USPTO granted patents. Top assignee: Diamond Shamrock Corporation. Active years: 1976-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alex Hlynsky. Retrieved from https://idiyas.com/inventor/alex-hlynsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1976-1981

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alex Hlynsky

Introduction

Alex Hlynsky is a notable inventor based in Mentor, OH (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on the synthesis of valuable compounds that have practical applications in medicine.

Latest Patents

One of Hlynsky's latest patents is the "Quinoline catalyzed synthesis of pyridazinone pharmaceutical." This innovative process allows for the preparation of valuable pyridazinone intermediates in surprisingly high yields. The method involves the quinoline catalyzed reaction of the corresponding monohydrazone with an appropriately substituted acetic acid ester. In a preferred embodiment, p,p'-dichlorobenzil monohydrazone and methyl acetoacetate are reacted in a xylene solvent in the presence of quinoline. This reaction produces 4-acetyl-5,6-bis(p-chlorophenyl)-2H-pyridazin-3-one, which can subsequently be transformed into the antihypertensive agent, 4-acetyl-5,6-bis(p-chlorophenyl)-2-(2'-hydroxyethyl)-2H-pyridazin-3-one.

Another significant patent is the "Cis-2,5-dialkylpyrrolidine process." This process produces a cis-2,5-dialkylpyrrolidine from 2,5-dialkylpyrrole or 2,5-dialkyl-1-pyrroline through an improved hydrogenation process. This method utilizes a ruthenium metal catalyst on an alumina or titania support, showcasing Hlynsky's innovative approach to chemical synthesis.

Career Highlights

Alex Hlynsky is currently employed at Diamond Shamrock Corporation, where he continues to develop and refine his innovative processes. His work has had a significant impact on the pharmaceutical industry, particularly in the synthesis of compounds that are essential for drug development.

Collaborations

Hlynsky has collaborated with notable colleagues, including Michael F DePompei and Jan M Griggs. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Alex Hlynsky's contributions to the field of pharmaceuticals through his innovative

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…